Hayden Michael R: insider buys
Every open-market stock purchase reported by Hayden Michael R to the SEC on Form 4.
Total bought$2.11M
Purchases3
Companies2
Last purchase filedAug 24, 2026
Return on these buys-0.6%
Hayden Michael R has made 3 open-market purchases worth $2.11M in 2 companies since Jul 31, 2026, according to SEC Form 4 filings. The most recent was filed on Aug 24, 2026: 53,613 shares of ABCL at $10.64 (Director), worth $570.44K. The largest was $1.06M of IONS on Jul 30, 2026. Taken together, these purchases are down 1% at the latest closing prices (split-adjusted, weighted by amount).
Companies Hayden Michael R bought
| Ticker | Company | Role | Buys | Total | Since buy | Last filed |
|---|---|---|---|---|---|---|
| IONS | Ionis Pharmaceuticals Inc | Director | 1 | $1.06M | -18% | Jul 31 |
| ABCL | AbCellera Biologics Inc. | Director | 2 | $1.05M | +17% | Aug 24 |
Get the next Hayden Michael R purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll purchases
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24 | ABCLAbCellera Biologics Inc. | Hayden Michael RDirector | $570.44K | 53,613 | $10.64 | +15% | +4% | Aug 24 | SEC |
| Aug 14 | ABCLAbCellera Biologics Inc. | Hayden Michael RDirector | $481.03K | 46,387 | $10.37 | +18% | +4% | Aug 12 | SEC |
| Jul 31 | IONSIonis Pharmaceuticals Inc | Hayden Michael RDirector | $1.06M | 20,000 | $52.94 | -18% | +500% | Jul 30 | SEC |